Sign in to view content

Subretinal Laru-zova Gene Therapy for XLRP: 24-Month Results of the Randomized, Controlled, Multicenter Phase 2 SKYLINE Trial

Robert Andrew Sisk, MD, FACS, FASRS

Video
Published 2025

Related

Complications of Transvitreal Subretinal Injections for Gene Therapy Vectors in Inherited Retinal Diseases
Chloe TL Khoo, MD
Annual Meeting Talks
2023
Intravitreal AAVCAGsCD59 as Adjunct Anti-VEGF Treatment for Wet Age-Related Macular Degeneration
Jeffrey S. Heier, MD
Annual Meeting Talks
2020
Surgical Case Conference: Sengul Ozdek, MD, FEBO, FASRS
Sengul Ozdek, MD, FEBO, FASRS
Annual Meeting Talks
2024

Category: Hereditary Retinal Disease & Genetics

See more